Which company's drug is Talazoparib? How much?

Talazoparib is a poly(ADP-ribose) polymerase (PARP) inhibitor developed by Pfizer Pharmaceuticals. Pfizer is a pharmaceutical company with a long history and strong strength, always committed to providing safe and effective medicines to patients around the world. In terms of research and development of anti-cancer drugs, Pfizer has launched a number of innovative drugs, bringing treatment hope to patients around the world. The successful development of talazoparib once again proves Pfizer’s leading position and innovation capabilities in the pharmaceutical field. The drug is currently approved for the treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm) HER2-negative locally advanced or metastatic breast cancer. At the same time, it can also be used in combination with enzalutamide for the treatment of adult patients with HRR gene-mutated metastatic castration-resistant prostate cancer (mCRPC).

Regarding the price of talazoparib, due to differences in economic levels, medical policies, market supply and demand and other factors in different countries and regions, there are certain price fluctuations.

According to the latest market data, the price of Pfizer's talazoparib original drug in overseas markets is approximately more than 18,000 yuan per box The price of 0.25mg*30 pills is about more than 18,000 yuan, while the price of 1mg*30 pills is nearly 50,000 yuan. In addition, in Laos, patients can also choose to purchase generic drugs of talazoparib. The price of generic drugs produced by Element Pharmaceuticals is relatively low. A box of 1mg*30 pills sells for about 4,000 yuan, which reduces the burden on patients. However, patients must ensure that the drugs come from regular channels when purchasing.

It should be emphasized that as a prescription drug, talazoparib must be used under the guidance of a doctor. When purchasing and using this drug, patients should fully understand its efficacy, possible side effects, precautions and other information, and maintain close communication with their doctors.